AMENDMENT AGREEMENT
Exhibit 10.68
THIS AMENDMENT AGREEMENT (this “Amendment”) is made and entered into as of the
5th day of December, 2006, by and between MEDCATH CORPORATION, a Delaware corporation
(the “Company”), and XXXX XxXXXXXXX (the “Executive”).
STATEMENT OF PURPOSE
The Company and the Executive are parties to an Amended and Restated Employment Agreement
dated September 30, 2005, as amended by a First Amendment thereto dated September 1, 2006 (the
“Employment Agreement”). The Employment Agreement provides that the Executive is entitled
to certain severance payments in the event of the Executive’s termination prior to or following a
“Change in Control” of the Company. The Company and the Executive have also entered into equity
award agreements (collectively, the “Grant Agreements”) which granted the Executive stock
options and restricted stock awards under the Company’s equity incentive plans. The Grant
Agreements provide that the stock options and awards will become fully vested, exercisable and free
of any resale restrictions upon a “Change in Control” of the Company. The Employment Agreement and
the Grant Agreements currently include in the definition of “Change in Control” a sale of voting
control in the Company by Kohlberg Kravis Xxxxxxx & Co., LLC (“KKR”) or Welsh, Carson,
Xxxxxxxx & Xxxxx VII, L.P. (“WCAS”) or any their affiliates.
On November 3, 2006, KKR, WCAS and their affiliates completed a secondary offering of a
portion of the shares of common stock held by them, and as a result, they ceased to own voting
control of the Company. The Company and the Executive desire to amend the definition of “Change in
Control” in the Employment Agreement and the Grant Agreements to make it clear that a “Change in
Control” will occur if any person (other than KKR, WCAS and their affiliates) acquires voting
control of the Company, whether or not the acquisition of such voting control results from a sale
of Company stock by KKR, WCAS or their affiliates.
NOW, THEREFORE, the Company and the Executive hereby agree that the definition of “Change in
Control” in the Employment Agreement and the Grant Agreements is amended effective as of the date
hereof to read as follows:
“For purposes of this Agreement, “Change in Control” means:
(i) Sales of all or substantially all of the assets of the Company,
MedCath Holdings Corp. or MedCath Incorporated to an individual,
partnership, corporation, business trust, joint stock company, trust,
unincorporated association, joint venture, governmental authority or other
entity (a “Person”) who is not an affiliate of Kohlberg Kravis
Xxxxxxx & Co., LLC (“KKR”) or Welsh, Carson, Xxxxxxxx & Xxxxx, VII,
L.P. (“WCAS” and together with KKR, the “Partnerships”);
(ii) Any “person” or “group” (as such terms are used in Section 13(d)
or 14(d) of the Securities Exchange Act of 1934 and the rules thereunder)
other than either of the Partnerships acquires and becomes the
“beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the
Securities Exchange Act of 1934), directly or indirectly, of 50% or more of
the voting stock of the Company, MedCath Holdings Corp. or MedCath
Incorporated; or
(iii) A merger or consolidation of the Company, MedCath Holdings Corp.
or MedCath Incorporated into another Person which is not an affiliate of
either of the Partnerships;
provided, however, that in the event that the Company, MedCath
Holdings Corp. or MedCath Incorporated is merged with another company controlled by
either of the Partnerships or their affiliates and, if the chief executive officer
of the surviving entity (or the ultimate parent) is not a person who has held the
position of chief executive officer of the Company for at least six months, such an
event shall be deemed a Change in Control.”
Except as expressly or by necessary implication amended hereby, the Employment Agreement and
the Grant Agreements shall continue in full force and effect.
IN WITNESS WHEREOF, the Company and the Executive have caused this Amendment to be executed as
of the day and year first above written.
| MEDCATH CORPORATION |
||||
| By: | /s/ O. XXXXX XXXXXX | |||
| O. Xxxxx Xxxxxx, President | ||||
| EXECUTIVE |
||||
| /s/ XXXX XXXXXXXXX | ||||
| Xxxx XxXxxxxxx | ||||
2
